[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"radiation-protection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:radiation-protection":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,39],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":14,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100628905","study-to-evaluate-the-clinical-utility-of-radiation-exposure-reduction-multi-site-rampart-guardian-peripheral-trial-100628905",false,"NCT07467720","Study to Evaluate the Clinical Utility of Radiation Exposure Reduction: Multi-site Rampart Guardian Peripheral Trial","Study to Evaluate the Clinical Utility of Radiation Exposure Reduction (SECURE): Multi-site Rampart Guardian Peripheral Trial","SECURE","Inclusion Criteria:\n\n* Member of the interventional care team\n* Elective peripheral procedure\n* The access site is the femoral artery\n* The treatment area is at or distal to the iliac artery\n\nExclusion Criteria:\n\n* Individuals who are not yet adults, pregnant women, or prisoners.\n* Urgent and emergent cases","ALL",{"count":19,"type":20},75,"ESTIMATED","INTERVENTIONAL",[23],"NA",[25],"Radiation Protection","NOT_YET_RECRUITING","2026-03-16",{"date":29,"type":30},"2026-03-18","ACTUAL",{"date":32,"type":20},"2026-05-15",{"date":34,"type":20},"2027-05-15",{"name":36,"class":37},"Baylor Research Institute","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":44,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":17,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":38},"100569239","next-generation-photon-counting-ct-technology-development-and-clinical-evaluation-100569239","NCT06691659","Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation","CT-DACE","Inclusion Criteria:\n\n* Age 18 to 89.\n* Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.\n* Not pregnant (based on attestation)\n\nExclusion Criteria:\n\n* Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant before CT imaging.\n* Participants with a known contrast allergy.\n* Any current medical condition, illness, or disorder, as assessed by medical record review and\u002For self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.","18 Years","89 Years",{"count":49,"type":20},250,"OBSERVATIONAL","This project aims to develop and evaluate a next-generation photon-counting CT prototype, and assess whether next-generation photon-counting CT--which enables reduced radiation dose, high spatial resolution, and spectral imaging--would facilitate improved diagnostic performance for abdominal, cardiothoracic, musculoskeletal, and neuroimaging.",[25,53],"Image Enhancement","RECRUITING","2025-10-09",{"date":57,"type":30},"2025-10-14",{"date":59,"type":30},"2024-11-19",{"date":61,"type":20},"2026-11-30",{"name":63,"class":37},"University of Pennsylvania"]